1. Real-world tolerability of biosimilar bevacizumab-awwb compared to bevacizumab in patients with cancer at an academic medical center. Issue 28 (1st October 2022) Authors: Alhaja, Maher; Tsourounis, Candy; Ho, Hansen; Fong, Richard Journal: Journal of clinical oncology Issue: Volume 40:Issue 28(2022)Supplement Page Start: 322 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗